OGT, Aushon, and Gentel Ink Separate Deals to Bolster Their Place in Protein-Array Market
March 17, 2009
OGT, Aushon, and Gentel Ink Separate Deals to Bolster Their Place in Protein-Array Market
Over the past week, OGT acquired protein-array maker Sense Proteomic, Aushon bought Thermo's SearchLight protein-array business, and Gentel and Eprogen allied to help drug makers identify new autoantibody biomarkers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Gentel Prepares to Launch APiX Platform, Assays in H1 as It Looks to Build Services Arm
February 3, 2009 / BioArray News - BioArray Briefs
April 7, 2009 / BioArray News - Genomics vs. Cancer
March 26, 2009 / Genome Technology - OGT Acquires Sense Proteomic
March 17, 2009 / GenomeWeb Daily News - Gentel, Eprogen Ink Proteome Array Pact
March 11, 2009 / GenomeWeb Daily News